Member Info for Laura2022

No dicko

See my posts ..I was buying 0.55-0.65

Your 1mln now showing Troutisout

The person who bought 867k Friday waited 1 day

Why bother!

Yes

All points summarised 3mths ago.

Must be large trades to show as volume showing 21mln

Includes healthcare and NHS

Thanks Truth

Again, similar to Friday

I am not getting a qoute to buy 300,000 at 0.8p ?

Nice amount purchased

Trout

Point taken

But not why you choose to pick me up on my postings that are constructive and factual but NOT those (jaari etc) posting untruths

Point taken though

Bezt wishes

See my conversation with the company 2mths ago

PYC at £1.6mln market value is the next FAB/IMM

I've been buying sub 0 6p before Christmas

Yes bah

Some have been like this for 12-15mths and commented on no other shares

Looks like a busy weekend for the non- invested

Shows the value for the right drug pipeline

Yet another £1 Billion takeover announced today (13th January 2025) in our sector with GSK buying IDRx for 1 Billion upfront and 150 Million in extras. Come on Stephen Parker and John Reader get on with it please......

Details below:

· Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

· IDRX-42 offers potential to address all key KIT mutations in GIST that drive tumour growth and progression and improve tolerability, gaps in current therapies

· Acquisition adds to GSK's growing portfolio in gastrointestinal (GI) cancers

· GSK to pay up to $1.15 billion

3

Nothing to concern

Miton have had redemptions across the board

And we don't just have the core business

We have newly emerged biostatistics

And also the potentially lucrative A.I dosing tools ( one with DosemeRx and the other NHS Trial one mentioned last week in the JV with NHS/beyond blood)

Plus our Virtual Tumour technology is fully fledged and now endorsed publicly

Porky

Why didn't you put this much effort into your DDDD due diligence or your cure3nt GDR holding which you said should be 50p+

Pmsl

Think I'll take the lead from the company rather than some sad keyboard warrior who clearly has no life on a Saturday night other than to plague a discussion group

You need help

This joint publication between Physiomics and Astellas demonstrates the impact of using modelling and simulation approaches to accelerate the development of innovative therapies across a range of therapeutic areas and throughout the entire drug development pathway, including early discovery and clinical development. The peer-reviewed article also demonstrates the power of Physiomics' Virtual Tumour platform in supporting world-leading pharmaceutical companies develop these important new therapies

Go and spend some time with your friend so or family

You're getting agitated

Imagine..!! 20+ posts on PYC...more than all your other shares combined